Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 33 | 2026 | 760 | 4.830 |
Why?
|
| Genetic Vectors | 29 | 2026 | 929 | 4.010 |
Why?
|
| Genetic Therapy | 19 | 2026 | 852 | 1.930 |
Why?
|
| Transduction, Genetic | 8 | 2026 | 242 | 1.390 |
Why?
|
| Capsid | 5 | 2026 | 104 | 1.230 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 5 | 2017 | 142 | 1.210 |
Why?
|
| Osteoblasts | 6 | 2019 | 204 | 1.060 |
Why?
|
| Transgenes | 9 | 2026 | 207 | 1.050 |
Why?
|
| Codon | 1 | 2025 | 60 | 0.860 |
Why?
|
| Retina | 2 | 2026 | 135 | 0.840 |
Why?
|
| Nanopores | 1 | 2022 | 14 | 0.750 |
Why?
|
| Cell Differentiation | 4 | 2017 | 1389 | 0.740 |
Why?
|
| Protein Biosynthesis | 1 | 2025 | 333 | 0.730 |
Why?
|
| Gene Expression | 4 | 2019 | 854 | 0.730 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 408 | 0.680 |
Why?
|
| Gene Transfer Techniques | 9 | 2025 | 325 | 0.670 |
Why?
|
| Animals | 36 | 2026 | 21450 | 0.630 |
Why?
|
| Mice | 27 | 2026 | 11172 | 0.630 |
Why?
|
| Capsid Proteins | 4 | 2026 | 107 | 0.610 |
Why?
|
| Promoter Regions, Genetic | 8 | 2026 | 689 | 0.600 |
Why?
|
| Osteogenesis | 3 | 2017 | 154 | 0.590 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 80 | 0.560 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 105 | 0.560 |
Why?
|
| Genome, Viral | 5 | 2024 | 145 | 0.560 |
Why?
|
| Genome | 2 | 2017 | 286 | 0.530 |
Why?
|
| CCCTC-Binding Factor | 1 | 2017 | 42 | 0.530 |
Why?
|
| Deoxyribonucleases | 1 | 2017 | 32 | 0.520 |
Why?
|
| Gene Expression Regulation | 3 | 2025 | 1633 | 0.480 |
Why?
|
| Liver | 4 | 2025 | 874 | 0.470 |
Why?
|
| Genes, Reporter | 4 | 2019 | 257 | 0.430 |
Why?
|
| MicroRNAs | 4 | 2025 | 714 | 0.430 |
Why?
|
| Muscular Atrophy, Spinal | 2 | 2026 | 25 | 0.430 |
Why?
|
| Eukaryota | 1 | 2014 | 31 | 0.410 |
Why?
|
| Cell Line | 8 | 2019 | 2029 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 9 | 2026 | 3500 | 0.360 |
Why?
|
| Organ Specificity | 2 | 2025 | 200 | 0.350 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 84 | 0.350 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 98 | 0.330 |
Why?
|
| Genomics | 1 | 2014 | 386 | 0.330 |
Why?
|
| Macular Degeneration | 2 | 2026 | 196 | 0.330 |
Why?
|
| Humans | 32 | 2026 | 65632 | 0.330 |
Why?
|
| Genetic Engineering | 3 | 2019 | 114 | 0.300 |
Why?
|
| HEK293 Cells | 4 | 2025 | 617 | 0.260 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 196 | 0.250 |
Why?
|
| Gene Editing | 3 | 2021 | 331 | 0.250 |
Why?
|
| Gene Silencing | 2 | 2019 | 436 | 0.240 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2026 | 12 | 0.240 |
Why?
|
| DNA, Circular | 1 | 2025 | 7 | 0.230 |
Why?
|
| Liver Failure, Acute | 1 | 2025 | 25 | 0.220 |
Why?
|
| Acetaminophen | 1 | 2025 | 53 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2025 | 53 | 0.220 |
Why?
|
| Plasmids | 2 | 2023 | 294 | 0.210 |
Why?
|
| Carcinogenesis | 2 | 2023 | 135 | 0.210 |
Why?
|
| Recombinational DNA Repair | 2 | 2021 | 29 | 0.210 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1291 | 0.210 |
Why?
|
| Brain | 2 | 2025 | 1618 | 0.200 |
Why?
|
| Recombination, Genetic | 1 | 2025 | 256 | 0.200 |
Why?
|
| Hepatocytes | 1 | 2025 | 226 | 0.200 |
Why?
|
| Central Nervous System | 3 | 2020 | 200 | 0.190 |
Why?
|
| Terminal Repeat Sequences | 1 | 2022 | 13 | 0.190 |
Why?
|
| Recombinant Proteins | 1 | 2025 | 709 | 0.190 |
Why?
|
| Gene Order | 2 | 2019 | 33 | 0.180 |
Why?
|
| Baculoviridae | 1 | 2022 | 24 | 0.180 |
Why?
|
| Insecta | 1 | 2022 | 36 | 0.180 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 10 | 0.180 |
Why?
|
| Tyrosinemias | 1 | 2021 | 20 | 0.170 |
Why?
|
| Transfection | 3 | 2025 | 700 | 0.170 |
Why?
|
| Retinal Vasculitis | 1 | 2021 | 9 | 0.170 |
Why?
|
| Microglia | 1 | 2024 | 254 | 0.170 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 55 | 0.170 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 28 | 0.170 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 909 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 316 | 0.160 |
Why?
|
| Lentivirus | 1 | 2021 | 64 | 0.160 |
Why?
|
| Communicable Diseases | 1 | 2021 | 86 | 0.160 |
Why?
|
| DNA, Viral | 2 | 2020 | 232 | 0.160 |
Why?
|
| Cisterna Magna | 1 | 2019 | 17 | 0.150 |
Why?
|
| Algorithms | 1 | 2025 | 1051 | 0.150 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 40 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2021 | 239 | 0.150 |
Why?
|
| Bone Resorption | 1 | 2019 | 46 | 0.150 |
Why?
|
| Ovalbumin | 1 | 2019 | 108 | 0.150 |
Why?
|
| Immunotherapy | 1 | 2021 | 274 | 0.140 |
Why?
|
| Genes, Recessive | 1 | 2018 | 51 | 0.140 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 170 | 0.140 |
Why?
|
| Osteoporosis | 1 | 2019 | 113 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 152 | 0.140 |
Why?
|
| Neoplasms | 2 | 2021 | 1376 | 0.140 |
Why?
|
| Immunity, Innate | 2 | 2021 | 829 | 0.130 |
Why?
|
| Heterozygote | 1 | 2018 | 173 | 0.130 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 24 | 0.130 |
Why?
|
| Gene Ontology | 1 | 2017 | 38 | 0.130 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 14 | 0.130 |
Why?
|
| Introns | 1 | 2017 | 114 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 797 | 0.130 |
Why?
|
| Computational Biology | 1 | 2019 | 368 | 0.130 |
Why?
|
| Alleles | 1 | 2018 | 455 | 0.130 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 100 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2018 | 142 | 0.120 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2016 | 5 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2014 | 2189 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2026 | 2319 | 0.120 |
Why?
|
| Alphavirus | 1 | 2015 | 3 | 0.120 |
Why?
|
| Colforsin | 1 | 2015 | 25 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2017 | 282 | 0.110 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 87 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2014 | 1559 | 0.110 |
Why?
|
| Cyclic AMP | 1 | 2015 | 144 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 238 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 111 | 0.100 |
Why?
|
| Luciferases | 1 | 2014 | 107 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 788 | 0.100 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 369 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2014 | 201 | 0.100 |
Why?
|
| Risk Factors | 1 | 2023 | 5466 | 0.100 |
Why?
|
| Metalloproteases | 1 | 2013 | 4 | 0.100 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2013 | 12 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 542 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 36 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1226 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2026 | 234 | 0.090 |
Why?
|
| Frozen Sections | 1 | 2012 | 11 | 0.090 |
Why?
|
| Base Sequence | 1 | 2014 | 1331 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2012 | 127 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 146 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1979 | 0.080 |
Why?
|
| Monocytes | 1 | 2013 | 361 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 663 | 0.080 |
Why?
|
| Serogroup | 2 | 2020 | 35 | 0.080 |
Why?
|
| Mutation | 1 | 2018 | 2670 | 0.080 |
Why?
|
| Chromatin | 1 | 2014 | 643 | 0.070 |
Why?
|
| Male | 8 | 2026 | 31281 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 2 | 2021 | 180 | 0.070 |
Why?
|
| Virus Assembly | 2 | 2020 | 54 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2016 | 3162 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 241 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 876 | 0.060 |
Why?
|
| Ferrets | 1 | 2025 | 11 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2025 | 15 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2025 | 38 | 0.060 |
Why?
|
| Myocardium | 1 | 2007 | 302 | 0.050 |
Why?
|
| Binding Sites | 2 | 2021 | 917 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2026 | 503 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2026 | 175 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2026 | 308 | 0.050 |
Why?
|
| Female | 5 | 2026 | 34294 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2024 | 219 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2017 | 385 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2021 | 17 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 986 | 0.040 |
Why?
|
| Dystrophin | 1 | 2021 | 30 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1573 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 104 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 31 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 55 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 83 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 105 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 397 | 0.040 |
Why?
|
| Vaccines | 1 | 2021 | 97 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 44 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 56 | 0.040 |
Why?
|
| Catheters | 1 | 2019 | 76 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 35 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 194 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 140 | 0.040 |
Why?
|
| RNA Stability | 1 | 2019 | 104 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2019 | 111 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 399 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1710 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 242 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2019 | 169 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2019 | 266 | 0.030 |
Why?
|
| Muscles | 1 | 2019 | 179 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 193 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 13 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 218 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 312 | 0.030 |
Why?
|
| DNA End-Joining Repair | 1 | 2018 | 26 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 277 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 869 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 251 | 0.030 |
Why?
|
| Endonucleases | 1 | 2018 | 84 | 0.030 |
Why?
|
| Blastocyst | 1 | 2018 | 74 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 115 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 754 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 372 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2016 | 30 | 0.030 |
Why?
|
| Response Elements | 1 | 2016 | 41 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2019 | 531 | 0.030 |
Why?
|
| RNA Interference | 1 | 2019 | 647 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2016 | 83 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 514 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2015 | 50 | 0.030 |
Why?
|
| Oncolytic Virotherapy | 1 | 2015 | 9 | 0.030 |
Why?
|
| Oncolytic Viruses | 1 | 2015 | 10 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 417 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 53 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 62 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 269 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 250 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 964 | 0.030 |
Why?
|
| Synteny | 1 | 2014 | 24 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 679 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2168 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 497 | 0.020 |
Why?
|
| ADAM17 Protein | 1 | 2013 | 8 | 0.020 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 21 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 2013 | 29 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 588 | 0.020 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 46 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 160 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 741 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 342 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1193 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1660 | 0.020 |
Why?
|
| COS Cells | 1 | 2012 | 180 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 103 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 2392 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2252 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1100 | 0.020 |
Why?
|
| Proteomics | 1 | 2012 | 299 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1633 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 1996 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2007 | 7 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2007 | 42 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 233 | 0.020 |
Why?
|